New Zealand - English - Ministry for Primary Industries

genera ltd - aluminium phosphide - aluminium phosphide 570 g/kg - insecticide

Malta - English - Medicines Authority

sanofi pasteur 14 espace henry vallée , 69007 lyon, france - tetanus toxoid, diphtheria toxoid, pertussis toxoid, filamentous haemagglutinin, fha, pertactin, fimbriae types, and, aluminium phosphate - suspension for injection in pre-filled syringe - aluminium phosphate 1.5 mg tetanus toxoid 20 iu diphtheria toxoid 2 iu pertussis toxoid 2.5 µg filamentous haemagglutinin (fha) 5 µg pertactin 3 µg fimbriae types 2 and 3 5 µg - vaccines

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

titan ag pty ltd - phosphine (ph3) present as aluminium phosphide - tablet (inc. pellet, bolus, suppository, capsule) - phosphine (ph3) present as aluminium phosphide gas active 330.0 g/kg - insecticide

Australia - English - Department of Health (Therapeutic Goods Administration)

otsuka australia pharmaceutical pty ltd - aripiprazole, quantity: 5 mg - tablet, uncoated - excipient ingredients: magnesium stearate; maize starch; hyprolose; lactose monohydrate; microcrystalline cellulose; indigo carmine aluminium lake - - abilify is indicated for the treatment of schizophrenia including maintenance of clinical improvement during continuation therapy. - acute treatment of manic or mixed episodes associated with bipolar i disorder in adults as monotherapy and in combination with lithium or valproate; - maintenance treatment of manic or mixed episodes in bipolar i disorder in adults as monotherapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - aluminium hydroxide, quantity: 600 mg - tablet, film coated - excipient ingredients: purified talc; macrogol 8000; microcrystalline cellulose; hydrogenated vegetable oil; sodium starch glycollate; magnesium stearate; pregelatinised maize starch; titanium dioxide; hypromellose; brilliant blue fcf; sunset yellow fcf; polysorbate 80; quinoline yellow; macrogol 400; propylene glycol; macrogol 3350 - symptomatic relief of uncomplicated peptic ulcer and gastric hyperacidity. phosphate binding in renal dysfunction.

Australia - English - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - aluminium sulfate hydrate, quantity: 200 mg/ml - gel - excipient ingredients: sodium laureth sulfate; purified water; colloidal anhydrous silica; nonoxinol 10; fragrance (perfume); sodium lauryl sulfate; sodium cetostearyl sulfate; laureth-10 - stingose relieves the pain of stings and bites of most insects and plants such as ants, bees, wasps, mosquitoes and nettles. stingose helps to minimise inflammation, swelling, blistering and itching due to stings and bites.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - aluminium sulfate hydrate, quantity: 200 mg/ml - spray, solution - excipient ingredients: sodium laureth sulfate; purified water; fragrance (perfume) - helps to minimise the pain, inflammation, and itching associated with stings and bites of most insects and plants, including ants, bees, wasps, mosquitos, sandflies, sea lice, vines and nettles.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - aprepitant, quantity: 165 mg - capsule - excipient ingredients: hypromellose; poloxamer; sucrose; microcrystalline cellulose; gelatin; sodium lauryl sulfate; titanium dioxide; indigo carmine aluminium lake; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid - aprepitant, in combination with other antiemetic agents, is indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of: - highly emetogenic cancer chemotherapy. - moderately emetogenic cancer chemotherapy. aprepitant is indicated for the prevention of postoperative nausea and vomiting.

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - aprepitant, quantity: 80 mg - capsule, hard - excipient ingredients: hypromellose; sodium lauryl sulfate; gelatin; titanium dioxide; poloxamer; microcrystalline cellulose; sucrose; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid - aprepitant in combination with other antiemetic agents, is indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of:,? highly emetogenic cancer chemotherapy.,? moderately emetogenic cancer chemotherapy,aprepitant is indicated for the prevention of postoperative nausea and vomiting.

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - aprepitant, quantity: 125 mg - capsule, hard - excipient ingredients: microcrystalline cellulose; sucrose; hypromellose; poloxamer; gelatin; sodium lauryl sulfate; titanium dioxide; iron oxide red; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid - aprepitant in combination with other antiemetic agents, is indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of:,? highly emetogenic cancer chemotherapy.,? moderately emetogenic cancer chemotherapy,aprepitant is indicated for the prevention of postoperative nausea and vomiting.